What is BCAX's dilution risk score?

BCAX has a latest available DilutionScore record of 33/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BCAX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BCAX?

DilutionWatch tracks 25 SEC filing types for BCAX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BCAX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BCAX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BCAX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BCAX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BCAX Dilution Risk Score: 33/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

0

📊 Float Risk

50

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for BCAX.

🔔 Track BCAX — Get forecast alerts →

Market Data

Market Cap$1.43B

Shares Outstanding66.17M

Float36.63M

Cash$414.71M

Debt$1.44M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 36.1% shares (2026Q1 vs prior)

149 institutional holders · 79.15M shares

#1 RA CAPITAL MANAGEMENT, L.P. 7.26M shares

#2 JANUS HENDERSON GROUP PLC 6.67M shares

#3 T. Rowe Price Investment Management, Inc. 6.61M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.60M

Days to Cover20.4

% of Float26.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31

4 INSIDER TRANSACTION 2026-03-26

4 INSIDER TRANSACTION 2026-03-24

4 INSIDER TRANSACTION 2026-03-17

4 INSIDER TRANSACTION 2026-03-11

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BCAX Dilution Snapshot

Bicara Therapeutics Inc. (BCAX) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for BCAX: 4 on 2026-03-26; 4 on 2026-03-24; 4 on 2026-03-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.